Anales RANF

Melatonin and melanopsin in the eye: friends or foes? @Real Academia Nacional de Farmacia. Spain 57 13. Aihara M, Lindsey JD, Weinreb RN. Twenty-four- hour pattern of mouse intraocular pressure. Exp Eye Res. 2003;77(6):681-6. 14. Acott TS, Kelley MJ, Keller KE, Vranka JA, Abu- Hassan DW, Li X, et al. Intraocular pressure homeostasis: maintaining balance in a high-pressure environment. J Ocul Pharmacol Ther. 2014;30(2- 3):94-101. 15. Pizzirani S. Definition, Classification, and Pathophysiology of Canine Glaucoma. Vet Clin North Am Small Anim Pract. 2015;45(6):1127-57, v. 16. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-7. 17. Quigley HA. Glaucoma. Lancet. 2011;377(9774):1367-77. 18. Martinelli AM. Glaucoma. Classifications, treatment options, patient care. AORN J. 1991;54(4):743-8, 50- 3, 55-7. 19. Rocca J. Galen on the brain: anatomical knowledge and physiological speculation in the second century AD. Stud Anc Med. 2003;26:1-313. 20. Blavatsky HP, Harry Houdini Collection (Library of Congress). The secret doctrine : the synthesis of science, religion, and philosophy. London New York Adyar, Madras: Theosophical Publishing Co. ; William Q. Judge ; Manager of The theosophist; 1888. 21. Shoja MM, Hoepfner LD, Agutter PS, Singh R, Tubbs RS. History of the pineal gland. Childs Nerv Syst. 2016;32(4):583-6. 22. Axelrod J. The pineal gland: a neurochemical transducer. Science. 1974;184(4144):1341-8. 23. Axelrod J, Weissbach H. Purification and properties of hydroxyindole-O-methyl transferase. J Biol Chem. 1961;236:211-3. 24. Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia. 1993;49(8):654-64. 25. Klein DC. Arylalkylamine N-acetyltransferase: "the Timezyme". J Biol Chem. 2007;282(7):4233-7. 26. Rohde BH, McLaughlin MA, Chiou LY. Existence and role of endogenous ocular melatonin. J Ocul Pharmacol. 1985;1(3):235-43. 27. Boutin JA. [Melatonin binding site MT3 is QR2: state of the art]. J Soc Biol. 2007;201(1):97-103. 28. Boutin JA, Marcheteau E, Hennig P, Moulharat N, Berger S, Delagrange P, et al. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate. J Pineal Res. 2008;45(4):524-31. 29. Alarma-Estrany P, Crooke A, Pintor J. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. J Pineal Res. 2009;47(2):201-9. 30. von Gall C, Weaver DR, Kock M, Korf HW, Stehle JH. Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor. Neuroreport. 2000;11(9):1803-7. 31. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev. 1998;78(3):687-721. 32. Tslm ST, Wong JT, Wong YH. CGP 52608-induced cyst formation in dinoflagellates: possible involvement of a nuclear receptor for melatonin. J Pineal Res. 1996;21(2):101-7. 33. Brydon L, Barrett P, Morgan PJ, Strosberg AD, Jockers R. Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies. Adv Exp Med Biol. 1999;460:215-20. 34. Petit L, Guardiola B, Delagrange P, Jockers R, Strosberg AD. [Signaling by melatonin receptors]. Therapie. 1998;53(5):421-8. 35. Bill A. Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp Eye Res. 1966;5(1):45-54. 36. Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47 Suppl 1:S53-64. 37. Civan MM, Macknight AD. The ins and outs of aqueous humour secretion. Exp Eye Res. 2004;78(3):625-31. 38. Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg. 2009;108(4):1146-51. 39. Martinez-Aguila A, Fonseca B, Bergua A, Pintor J. Melatonin analogue agomelatine reduces rabbit's intraocular pressure in normotensive and hypertensive conditions. Eur J Pharmacol. 2013;701(1-3):213-7. 40. Martinez-Aguila A, Fonseca B, Perez de Lara MJ, Pintor J. Effect of Melatonin and 5- Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice. J Pharmacol Exp Ther. 2016;357(2):293-9. 41. Pescosolido N, Gatto V, Stefanucci A, Rusciano D. Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients. Ophthalmic Physiol Opt. 2015;35(2):201-5. 42. Huete-Toral F, Crooke A, Martinez-Aguila A, Pintor J. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther. 2015;352(1):119-28. 43. Alcantara-Contreras S, Baba K, Tosini G. Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse. Neurosci Lett. 2011;494(1):61-4. 44. Belforte NA, Moreno MC, de Zavalia N, Sande PH, Chianelli MS, Keller Sarmiento MI, et al. Melatonin: a novel neuroprotectant for the treatment of glaucoma. J Pineal Res. 2010;48(4):353-64.